TrinityPoint Wealth LLC increased its holdings in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 3.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,669 shares of the company’s stock after acquiring an additional 218 shares during the period. TrinityPoint Wealth LLC’s holdings in Procter & Gamble were worth $1,155,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently made changes to their positions in PG. Concurrent Investment Advisors LLC lifted its holdings in Procter & Gamble by 4.5% in the third quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock valued at $16,300,000 after buying an additional 4,035 shares during the period. Radnor Capital Management LLC acquired a new position in Procter & Gamble in the 3rd quarter worth $5,705,000. Welch Group LLC boosted its position in shares of Procter & Gamble by 0.9% during the third quarter. Welch Group LLC now owns 323,870 shares of the company’s stock worth $56,094,000 after buying an additional 2,990 shares during the period. GAMMA Investing LLC lifted its position in shares of Procter & Gamble by 67.2% in the second quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock worth $4,420,000 after purchasing an additional 10,777 shares in the last quarter. Finally, Curi RMB Capital LLC lifted its position in Procter & Gamble by 20.3% during the 3rd quarter. Curi RMB Capital LLC now owns 21,655 shares of the company’s stock worth $3,751,000 after buying an additional 3,652 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction that occurred on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total value of $2,163,072.00. Following the completion of the transaction, the insider now directly owns 11,566 shares in the company, valued at $1,954,538.34. This represents a 52.53 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Andre Schulten sold 13,041 shares of the stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the sale, the chief financial officer now owns 37,208 shares of the company’s stock, valued at $6,325,360. This represents a 25.95 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 313,597 shares of company stock worth $53,268,499 over the last three months. 0.18% of the stock is currently owned by company insiders.
Procter & Gamble Stock Up 1.5 %
Procter & Gamble (NYSE:PG – Get Free Report) last released its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. During the same quarter last year, the business posted $1.83 earnings per share. The company’s revenue for the quarter was down .6% on a year-over-year basis. On average, equities research analysts anticipate that The Procter & Gamble Company will post 6.94 EPS for the current year.
Procter & Gamble Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a $1.0065 dividend. This represents a $4.03 annualized dividend and a dividend yield of 2.37%. The ex-dividend date was Friday, October 18th. Procter & Gamble’s dividend payout ratio is currently 69.48%.
Analyst Ratings Changes
Several research analysts have recently weighed in on the stock. Morgan Stanley boosted their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research note on Monday, October 21st. JPMorgan Chase & Co. boosted their price objective on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. Stifel Nicolaus increased their price target on Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research note on Monday, July 22nd. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Finally, StockNews.com downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Nine analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average target price of $177.00.
Get Our Latest Stock Report on PG
Procter & Gamble Company Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
See Also
- Five stocks we like better than Procter & Gamble
- What is a SEC Filing?
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- The 3 Best Fintech Stocks to Buy Now
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.